Why the study?
Does Losartan inhibit neointimal proliferation in cultured human saphenous veins?
Does Losartan inhibit neointimal proliferation in cultured human saphenous veins?
Answers are grounded in this paper and cite their sources.
Losartan reduces neointimal thickness and proliferation in human saphenous vein organ cultures, suggesting potential therapeutic value for modulating vein graft intimal hyperplasia.
An organ culture of human saphenous vein was used as a model of vein graft intimal hyperplasia and the potential of Losartan, an angiotensin II receptor antagonist, to inhibit neointimal proliferation was investigated. Median (range) neointimal thickness was reduced from 17 (16-19) to 11 (8-18) microns in veins cultured with Losartan (median difference 5 (95 per cent confidence interval 2-8) microns). A similar decrease in the median neointimal proliferation index was seen from 21 (range 14-47) to 15 (range 5-31) per cent (median difference 8 per cent (95 per cent confidence interval 5-11 per cent)). These results demonstrate that angiotensin II receptor antagonists may be of therapeutic value for the modulation of vein graft intimal hyperplasia.
No takes yet. Share an insight, caveat, or question.
Varty et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: